Eli Lilly’s oral obesity treatment efficacy falls short of expectations, says BMO’s Evan SeigermanAugust 7, 2025
Share Facebook Twitter LinkedIn Pinterest Email CNBC’s Kristina Partsinevelos and Stacy Rasgon, Bernstein senior U.S. semiconductor analyst, joins ‘Power Lunch’ to discuss the latest news in the semiconductor space, what Lip-Bu Tan leaving Intel would do for the company and much more.